Detalhe da pesquisa
1.
Treatment outcomes of complement protein C5 inhibition in 509 UK patients with paroxysmal nocturnal hemoglobinuria.
Blood
; 143(12): 1157-1166, 2024 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38142401
2.
Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia.
N Engl J Med
; 386(1): 11-23, 2022 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34986284
3.
Real-world experience of pegcetacoplan in paroxysmal nocturnal hemoglobinuria.
Am J Hematol
; 99(5): 816-823, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38348608
4.
The incidence and prevalence of patients with paroxysmal nocturnal haemoglobinuria and aplastic anaemia PNH syndrome: A retrospective analysis of the UK's population-based haematological malignancy research network 2004-2018.
Eur J Haematol
; 107(2): 211-218, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34060690
5.
Experience of compassionate-use pegcetacoplan for paroxysmal nocturnal hemoglobinuria.
Blood
; 141(1): 116-120, 2023 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36054920
6.
Impact of the type of anthracycline and of stem cell transplantation in younger patients with acute myeloid leukaemia: Long-term follow up of a phase III study.
Am J Hematol
; 95(7): 749-758, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32233095
7.
Impact of induction regimen and allogeneic hematopoietic cell transplantation on outcome in younger adults with acute myeloid leukemia with a monosomal karyotype.
Haematologica
; 104(6): 1168-1175, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30523055
8.
Phase II trials of zilucoplan in paroxysmal nocturnal hemoglobinuria.
Haematologica
; 109(3): 929-935, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37534517
9.
Eculizumab in Pregnant Patients with Paroxysmal Nocturnal Hemoglobinuria.
N Engl J Med
; 373(11): 1032-9, 2015 Sep 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-26352814
10.
Cytogenetic clonal heterogeneity is not an independent prognosis factor in 15-60-year-old AML patients: results on 1291 patients included in the EORTC/GIMEMA AML-10 and AML-12 trials.
Ann Hematol
; 97(10): 1785-1795, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29926156
11.
Genomic array as compared to karyotyping in myelodysplastic syndromes in a prospective clinical trial.
Genes Chromosomes Cancer
; 56(7): 524-534, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28236351
12.
Romiplostim monotherapy in thrombocytopenic patients with myelodysplastic syndromes: long-term safety and efficacy.
Br J Haematol
; 178(6): 906-913, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28616874
13.
Clinical course and disease burden in patients with paroxysmal nocturnal hemoglobinuria by hemolytic status.
Blood Cells Mol Dis
; 65: 29-34, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28437723
14.
Implementation of erythroid lineage analysis by flow cytometry in diagnostic models for myelodysplastic syndromes.
Haematologica
; 102(2): 320-326, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27658438
15.
Clinical benefit of eculizumab in patients with no transfusion history in the International Paroxysmal Nocturnal Haemoglobinuria Registry.
Intern Med J
; 47(9): 1026-1034, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28608499
16.
Decitabine improves progression-free survival in older high-risk MDS patients with multiple autosomal monosomies: results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group.
Ann Hematol
; 95(2): 191-9, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26596971
17.
Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies.
Kidney Int
; 87(5): 1061-73, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25651368
18.
COVID-19 infection in patients on anti-complement therapy: The Leeds National Paroxysmal Nocturnal Haemoglobinuria service experience.
Br J Haematol
; 191(1): e1-e4, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32945525
19.
Successful treatment of a PNH patient non-responsive to eculizumab with the novel complement C5 inhibitor coversin (nomacopan).
Br J Haematol
; 188(2): 334-337, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31840801
20.
Long-term follow-up of a trial comparing post-remission treatment with autologous or allogeneic bone marrow transplantation or intensive chemotherapy in younger acute myeloid leukemia patients.
Haematologica
; 105(1): e13-e16, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31097634